Entering text into the input field will update the search result below

Sarepta Therapeutics, Inc. (SRPT) Q1 2023 Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2023 Earnings Conference Call May 2, 2023 4:30 PM ET

Company Participants

Mary Jenkins – Associate Director-Investor Relations

Doug Ingram – President and Chief Executive Officer

Louise Rodino-Klapac – Executive Vice President, Head-R&D and Chief Scientific Officer

Dallan Murray – Executive Vice President and Chief Customer Officer

Ian Estepan – Executive Vice President and Chief Financial Officer

Conference Call Participants

Colin Bristow – UBS

Gena Wang – Barclays

Brian Abrahams – RBC Capital Markets

Judah Frommer – Credit Suisse

Salveen Richter – Goldman Sachs

Gil Blum – Needham and Company

Tazeen Ahmad – Bank of America

Danielle Brill – Raymond James

Mike Ulz – Morgan Stanley

Neena Bitritto-Garg – Citi

Tim Lugo – William Blair

Kristen Kluska – Cantor Fitzgerald

Hartaj Singh – Oppenheimer and Company

Debjit Chattopadhyay – Guggenheim

Joseph Schwartz – SVB Securities

Zhiqiang Shu – Berenberg

Gavin Clark-Gartner – Evercore ISI

Brian Skorney – Baird

Anupam Rama – JPMorgan


Good afternoon and welcome to the Sarepta Therapeutics First Quarter 2023 Earnings Call. At this time all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator instructions] As a reminder, today's program is being recorded.

At this time, I will turn the call over to Mary Jenkins, Associate Director, Investor Relations. Please go ahead.

Mary Jenkins

Thank you, Shannon, and thank you all for joining today's call. Earlier this afternoon, we released our financial results for the first quarter 2023. The press release is available on our website at sarepta.com, and our 10-Q was filed with the Securities and Exchange Commission this afternoon. Joining us on the call today are Doug Ingram, Ian Estepan, Dallan Murray, and Dr. Louise Rodino-Klapac. After our formal remarks, we'll open the call for Q&A. I'd like to note that during this call, we will be making a number of forward-looking statements. Please take a

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About SRPT Stock

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on SRPT

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.